quinuclidines has been researched along with pumosetrag in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blackshaw, E; Chan, PQ; Coleman, NS; Gowland, PA; Marciani, L; Parker, M; Perkins, AC; Spiller, RC; Wilde, K; Wright, J; Yamazaki, S; Yano, T | 1 |
| Fujita, T; Kumagai, Y; Majima, M; Ohtani, Y; Sawada, M; Yokota, S | 1 |
| Evangelista, S | 1 |
| Chetty, N; Coupar, IM; Irving, HR | 1 |
| Chai, W; Chan, KY; Danser, AH; de Maeyer, JH; de Vries, R; MaassenVanDenBrink, A; Saxena, PR; Schuurkes, JA; van den Bogeardt, AJ; Villalón, CM | 1 |
| Choung, RS; Crowell, MD; Devault, K; Francis, DD; Harmsen, WS; Katzka, D; Locke, GR; Orr, WC; Talley, NJ; Winkle, PJ; Zinsmeister, AR | 1 |
1 review(s) available for quinuclidines and pumosetrag
| Article | Year |
|---|---|
Drug evaluation: Pumosetrag for the treatment of irritable bowel syndrome and gastroesophageal reflux disease.
Topics: Animals; Dopamine Agents; Gastroesophageal Reflux; Gastrointestinal Agents; Humans; Irritable Bowel Syndrome; Pyridines; Quinuclidines; Receptors, Serotonin, 5-HT3; Treatment Outcome | 2007 |
3 trial(s) available for quinuclidines and pumosetrag
| Article | Year |
|---|---|
Effect of a novel 5-HT3 receptor agonist MKC-733 on upper gastrointestinal motility in humans.
Topics: Adolescent; Adult; Body Mass Index; Cross-Over Studies; Double-Blind Method; Gamma Cameras; Gastrointestinal Motility; Humans; Magnetic Resonance Imaging; Male; Manometry; Middle Aged; Pyridines; Quinuclidines; Radionuclide Imaging; Serotonin 5-HT3 Receptor Agonists; Serotonin Receptor Agonists; Stomach | 2003 |
Effect of MKC-733, a 5-HT receptor partial agonist, on bowel motility and symptoms in subjects with constipation: an exploratory study.
Topics: Adult; Aged; Constipation; Defecation; Feces; Female; Gastrointestinal Motility; Humans; Male; Middle Aged; Pyridines; Quinuclidines; Serotonin Receptor Agonists | 2005 |
Novel partial 5HT3 agonist pumosetrag reduces acid reflux events in uninvestigated GERD patients after a standard refluxogenic meal: a randomized, double-blind, placebo-controlled pharmacodynamic study.
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Partial Agonism; Female; Gastroesophageal Reflux; Heartburn; Humans; Male; Meals; Middle Aged; Pyridines; Quinuclidines; Serotonin 5-HT3 Receptor Agonists; Young Adult | 2014 |
2 other study(ies) available for quinuclidines and pumosetrag
| Article | Year |
|---|---|
Effects of the novel 5-HT3 agonist MKC-733 on the rat, mouse and guinea pig digestive tract.
Topics: Animals; Dose-Response Relationship, Drug; Female; Gastrointestinal Tract; Guinea Pigs; Male; Mice; Pyridines; Quinuclidines; Rats; Receptors, Serotonin, 5-HT3; Serotonin 5-HT3 Receptor Agonists; Serotonin Receptor Agonists; Species Specificity | 2008 |
Inotropic effects of prokinetic agents with 5-HT(4) receptor agonist actions on human isolated myocardial trabeculae.
Topics: 5-Methoxytryptamine; Adolescent; Adult; Aged; Benzofurans; Calcium Channels; Child; Cisapride; Female; Gastrointestinal Agents; Heart Atria; Heart Ventricles; Humans; Indoles; Male; Middle Aged; Muscle Contraction; Myocardium; Pyridines; Quinuclidines; Receptors, Serotonin, 5-HT4; Serotonin; Serotonin 5-HT4 Receptor Agonists; Serotonin Antagonists; Sulfonamides; Young Adult | 2012 |